Cited by CrossRef (27)
- Min Soo Kim, Kwang Wook Suh, Suntaek Hong, Wook Jin. TrkC promotes colorectal cancer growth and metastasis. Oncotarget 2017;8:41319

- Wuling Liu, Babu Gajendran, Klarke M. Sample, Chunlin Wang, Anling Hu, Beiling Chen, Yanmei Li, Eldad Zacksenhaus, Yaacov Ben-David. A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer. Cancer Gene Ther 2022;29:1590

- Kathleen M. Mulvaney, Jacob P. Matson, Priscila F. Siesser, Tigist Y. Tamir, Dennis Goldfarb, Timothy M. Jacobs, Erica W. Cloer, Joseph S. Harrison, Cyrus Vaziri, Jeanette G. Cook, Michael B. Major. Identification and Characterization of MCM3 as a Kelch-like ECH-associated Protein 1 (KEAP1) Substrate. Journal of Biological Chemistry 2016;291:23719

- Nyanbol Kuol, Lily Stojanovska, Vasso Apostolopoulos, Kulmira Nurgali. Role of the nervous system in cancer metastasis. J Exp Clin Cancer Res 2018;37

- Ivan de Jesus Salazar-Estrada, Karthik Shantharam Kamath, Fei Liu. Precision Targeting of Endogenous Epidermal Growth Factor Receptor (EGFR) by Structurally Aligned Dual-Modifier Labeling. ACS Pharmacol. Transl. Sci. 2022;5:859

- Min Soo Kim, Wook Jin. TrkB Inhibits the BMP Signaling-Mediated Growth Inhibition of Cancer Cells. Cancers 2020;12:2095

- Amir Tajbakhsh, Amin Mokhtari-Zaer, Mehdi Rezaee, Fahimeh Afzaljavan, Mehdi Rivandi, Seyed Mahdi Hassanian, Gordon A Ferns, Alireza Pasdar, Amir Avan. Therapeutic Potentials of BDNF/TrkB in Breast Cancer; Current Status and Perspectives. J. Cell. Biochem. 2017;118:2502

- Chih-Wei Lin, Tianqing Zheng, Geramie Grande, Alex R. Nanna, Christoph Rader, Richard A. Lerner. A new immunochemical strategy for triple-negative breast cancer therapy. Sci Rep 2021;11

- Mohammed Ageeli Hakami, Bader S. Alotaibi, Ali Hazazi, Alaa Shafie, Ahad Amer Alsaiari, Amal Adnan Ashour, Farah Anjum. Identification of potential inhibitors of tropomyosin receptor kinase B targeting CNS-related disorders and cancers. Journal of Biomolecular Structure and Dynamics 2023:1

- Jacopo Meldolesi. Reviews of Physiology, Biochemistry and Pharmacology Vol. 174. 2023.

- Rui Zhang, Jianguo Zhao, Lu Zhao. TRKB acts as a prognostic predictive marker in Her-2 positive breast cancer. Annals of Diagnostic Pathology 2022;60:152017

- Tianshu Xu, Yancan Liang, Zhiquan Huang, Zixian Huang. RUNX3: A Location-oriented Genome Coordinator. BIO Integration 2023;4:30

- Min Soo Kim, Wook Jin. TrkB-Induced Inhibition of R-SMAD/SMAD4 Activation is Essential for TGF-β-Mediated Tumor Suppressor Activity. Cancers 2020;12:1048

- Yalu Zhou, Saurabh Sinha, Joel L. Schwartz, Guy R. Adami. A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA. BMC Cancer 2019;19

- Min Kang, Kay Yi Chong, Tobias M. P. Hartwich, Fangfang Bi, Allyson K. Witham, David Patrick, Madeline J. Morrisson, Sarah L. Cady, Alexandra P. Cerchia, Dawn Kelk, Yifei Liu, Jonah Nucci, Oluwagbemisola Madarikan, Daiki Ueno, Brian M. Shuch, Yang Yang-Hartwich. Ovarian BDNF promotes survival, migration, and attachment of tumor precursors originated from p53 mutant fallopian tube epithelial cells. Oncogenesis 2020;9

- Kazumasa Moriwaki, Masaki Wada, Hiroko Kuwabara, Yusuke Ayani, Tetsuya Terada, Masaaki Higashino, Ryo Kawata, Michio Asahi. BDNF/TRKB axis provokes EMT progression to induce cell aggressiveness via crosstalk with cancer-associated fibroblasts in human parotid gland cancer. Sci Rep 2022;12

- Yansong Liu, Zhonghua Zhang, Xuefeng Gao, Qinghua Ma, Zhiyong Yu, Shuhong Huang. Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B. Cancer Letters 2022;535:215629

- Lei Zhu, Mu Chen, Bingsong Huang, Tao Zhang, Kui Chen, Hao Lian, Min Liu, Kaijun Zhao, Ying Pang, Jing Zhang, Qinchuan Li, Chunlong Zhong. Genomic Analysis Uncovers Immune Microenvironment Characteristics and Drug Sensitivity of Ferroptosis in Breast Cancer Brain Metastasis. Front. Genet. 2022;12

- Min Soo Kim, Won Sung Lee, Hanki Lee, Wook Jin. TrkC, a novel prognostic marker, induces and maintains cell survival and metastatic dissemination of Ewing sarcoma by inhibiting EWSR1-FLI1 degradation. Cell Death Dis 2022;13

- Bo Wu, Shu Yang, Haimei Sun, Tingyi Sun, Fengqing Ji, Yurong Wang, Lie Xu, Deshan Zhou. Keap1 Inhibits Metastatic Properties of NSCLC Cells by Stabilizing Architectures of F-Actin and Focal Adhesions. 2018;16:508

- Katarína Smolková, Edit Mikó, Tünde Kovács, Alberto Leguina-Ruzzi, Adrienn Sipos, Péter Bai. Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism. Antioxidants & Redox Signaling 2020;33:966

- Won-Jun Lee, Kyeong-Jun Kim, Md. Khaled Hossain, Hyeon-Yeol Cho, Jeong-Woo Choi. DNA–Gold Nanoparticle Conjugates for Intracellular miRNA Detection Using Surface-Enhanced Raman Spectroscopy. BioChip J 2022;16:33

- Mohammad Malekan, Sasan Salehi Nezamabadi, Elham Samami, Mehdi Mohebalizadeh, Amene Saghazadeh, Nima Rezaei. BDNF and its signaling in cancer. J Cancer Res Clin Oncol 2023;149:2621

- Akhileshwar Namani, Md. Matiur Rahaman, Ming Chen, Xiuwen Tang. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer. BMC Cancer 2018;18

- Bernadette Rogez, Quentin Pascal, Audrey Bobillier, François Machuron, Robert-Alain Toillon, Dominique Tierny, Valérie Chopin, Xuefen Le Bourhis. Expression and Prognostic Significance of Neurotrophins and Their Receptors in Canine Mammary Tumors. Vet Pathol 2020;57:507

- Kazumasa Moriwaki, Yusuke Ayani, Hiroko Kuwabara, Tetsuya Terada, Ryo Kawata, Michio Asahi. TRKB tyrosine kinase receptor is a potential therapeutic target for poorly differentiated oral squamous cell carcinoma. Oncotarget 2018;9:25225

- Vilson Serafim Junior, Glaucia Maria de Mendonça Fernandes, Juliana Garcia de Oliveira-Cucolo, Erika Cristina Pavarino, Eny Maria Goloni-Bertollo. Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer. Cytokine 2020;136:155270
